Advertisement

About the Cover

May 18, 2017; 129 (20)

Cover image expansion

Destabilizing Ezh2 protein in alloreactive T cells by the Hsp90 inhibitor AUY922 leads to inhibition of inflammation in graft-versus-host disease target organs, such as the skin and liver. See the article by Huang et al on page 2737.